Recent Company News

• 06:47 AM ET Dec 17, 2025
  

  Merck announces topline results from Phase 3 KEYNOTE-B15 trial in patients with muscle-invasive bladder cancer (MIBC) eligible for cisplatin-based chemotherapy ($98.27, 0.00)

• 11:03 PM ET Dec 16, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (65 total)

• 10:04 PM ET Dec 16, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (53 total)

• 11:12 PM ET Dec 15, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (82 total)

• 10:03 PM ET Dec 15, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (141 total)

• 10:10 PM ET Dec 14, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (202 total)

• 10:06 PM ET Dec 14, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (101 total)

• 06:42 PM ET Dec 10, 2025
  

  Astellas Pharma to present data on potential treatments for pancreatic and gastric/gastroesophageal junction (G/GEJ) cancer at ASCO GI Cancers Symposium (¥2074.0000, 0)

• 11:15 PM ET Dec 09, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (119 total)

• 10:08 PM ET Dec 09, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (149 total)